Mackay Shields LLC’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,802
Closed -$846K 1375
2019
Q3
$846K Sell
16,802
-149,642
-90% -$7.52M 0.01% 1158
2019
Q2
$8.39M Buy
166,444
+79,325
+91% +$3.85M 0.06% 384
2019
Q1
$4.05M Sell
87,119
-205,293
-70% -$10.4M 0.03% 540
2018
Q4
$14.4M Sell
292,412
-98,873
-25% -$5.62M 0.12% 220
2018
Q3
$24.3M Buy
391,285
+153,325
+64% +$9.32M 0.19% 146
2018
Q2
$12.8M Buy
+237,960
New +$11.9M 0.09% 289
2017
Q3
Sell
-1,029,504
Closed -$39.6M 160
2017
Q2
$39.6M Buy
+1,029,504
New +$37.7M 1.68% 21

Other funds holding EHC

Mackay Shields LLC's EHC Position: Q4 2019 in Review

Mackay Shields LLC sold out of Encompass Health (EHC) in Q4 2019, closing a stake of 16,802 shares — an estimated $846K sold.

Mackay Shields LLC first reported a position in EHC in Q2 2017 and held it in 7 quarters. The position peaked at $39.6M in Q2 2017. 397 funds tracked by Wall St. Rank hold EHC as of Q4 2019.

  • Mackay Shields LLC reported no remaining Encompass Health position as of Q4 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 16,802 Encompass Health shares in Q4 2019, an estimated $846K.
  • Mackay Shields LLC first reported a position in Encompass Health in Q2 2017 and held it in 7 quarters.
  • Mackay Shields LLC's Encompass Health position peaked at $39.6M in Q2 2017.
  • 397 funds tracked by Wall St. Rank held Encompass Health as of Q4 2019.

Based on Mackay Shields LLC's 13F filing for Q4 2019, filed 11 Feb 2020.